MAT1A and metabolic dysfunction-associated steatohepatitis: Moreover, mice lacking the MAT1A gene demonstrated reduced SAM/SAH levels and manifested spontaneous NASH at 9–10 months of age (Alarcón-Vila et al., 2023).